AR090619A2 - Uso de un compuesto de tiazol para la produccion de un medicamento - Google Patents

Uso de un compuesto de tiazol para la produccion de un medicamento

Info

Publication number
AR090619A2
AR090619A2 ARP130101121A ARP130101121A AR090619A2 AR 090619 A2 AR090619 A2 AR 090619A2 AR P130101121 A ARP130101121 A AR P130101121A AR P130101121 A ARP130101121 A AR P130101121A AR 090619 A2 AR090619 A2 AR 090619A2
Authority
AR
Argentina
Prior art keywords
production
tiazol
compound
medicinal product
group
Prior art date
Application number
ARP130101121A
Other languages
English (en)
Inventor
Ikezono Katsumi
Ohta Kazuhide
Maeda Takashi
Nagamoto Hisashi
Sekiguchi Kazuo
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR090619A2 publication Critical patent/AR090619A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Uso de por lo menos un compuesto seleccionado del grupo que consiste de derivados de tiazol y sales del mismo representadas por la fórmula general (1), en donde R¹ es un grupo fenilo que puede tener 1 a 3 grupos alcoxilo inferior como sustituyentes en el anillo fenilo; R² es un grupo piridilo que puede tener 1 a 3 grupos carboxilo como sustituyentes en el anillo piridina, para la producción de un medicamento para el tratamiento de enfermedad pulmonar obstructiva crónica. Reivindicación 2: El uso de acuerdo con la reivindicación 1, caracterizado porque el derivado de tiazol es ácido 6-[2-(3,4-dietoxifenil)-tiazol-4-il]piridin-2-carboxílico.
ARP130101121A 2001-07-24 2013-04-05 Uso de un compuesto de tiazol para la produccion de un medicamento AR090619A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001222768 2001-07-24

Publications (1)

Publication Number Publication Date
AR090619A2 true AR090619A2 (es) 2014-11-26

Family

ID=19056195

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP020102695A AR036179A1 (es) 2001-07-24 2002-07-18 Composicion farmaceutica para el tratamiento de una enfermedad pulmonar obstructiva cronica y uso de un compuesto de tiazol para prepararla
ARP130101121A AR090619A2 (es) 2001-07-24 2013-04-05 Uso de un compuesto de tiazol para la produccion de un medicamento

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP020102695A AR036179A1 (es) 2001-07-24 2002-07-18 Composicion farmaceutica para el tratamiento de una enfermedad pulmonar obstructiva cronica y uso de un compuesto de tiazol para prepararla

Country Status (16)

Country Link
US (2) US20040147563A1 (es)
EP (1) EP1411936B1 (es)
KR (1) KR100566709B1 (es)
CN (1) CN1267097C (es)
AR (2) AR036179A1 (es)
AT (1) ATE305299T1 (es)
BR (1) BR0208719A (es)
CA (1) CA2441804C (es)
DE (1) DE60206391T2 (es)
DK (1) DK1411936T3 (es)
ES (1) ES2249596T3 (es)
HK (1) HK1077216A1 (es)
MX (1) MXPA04000620A (es)
MY (1) MY128711A (es)
TW (1) TWI302456B (es)
WO (1) WO2003009844A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394753B (zh) * 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉(tetomilast)晶體
TW200815054A (en) * 2006-06-19 2008-04-01 Otsuka Pharma Co Ltd Methods of using a thiazole derivative
SG188852A1 (en) * 2008-03-14 2013-04-30 Otsuka Pharma Co Ltd Mmp-2 and/or mmp-9 inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132944T2 (de) 1990-11-30 2002-11-21 Otsuka Pharmaceutical Co., Ltd. Azolederivate als Inhibitor von Superoxide-Radikalen
WO1998008830A1 (de) * 1996-08-26 1998-03-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazol-derivate als selektive inhibitoren der pde-iv
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6727364B2 (en) * 2001-04-30 2004-04-27 The Procter & Gamble Company Triazole compounds useful in treating diseases associated with unwanted cytokine activity

Also Published As

Publication number Publication date
HK1077216A1 (en) 2006-02-10
ATE305299T1 (de) 2005-10-15
CA2441804A1 (en) 2003-02-06
KR20040028749A (ko) 2004-04-03
US20080081828A1 (en) 2008-04-03
US7932276B2 (en) 2011-04-26
EP1411936B1 (en) 2005-09-28
DK1411936T3 (da) 2005-12-27
US20040147563A1 (en) 2004-07-29
MY128711A (en) 2007-02-28
KR100566709B1 (ko) 2006-04-03
BR0208719A (pt) 2004-07-20
DE60206391D1 (de) 2006-02-09
TWI302456B (en) 2008-11-01
CN1267097C (zh) 2006-08-02
CA2441804C (en) 2007-05-08
ES2249596T3 (es) 2006-04-01
CN1633295A (zh) 2005-06-29
MXPA04000620A (es) 2004-06-25
WO2003009844A1 (en) 2003-02-06
AR036179A1 (es) 2004-08-18
EP1411936A1 (en) 2004-04-28
DE60206391T2 (de) 2006-07-13

Similar Documents

Publication Publication Date Title
BR0108374A (pt) Derivado de pirazina ou um sal deste, composição farmacêutica, e, derivado de fluoropirazina ou um sal deste
CA2406392A1 (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
UY27300A1 (es) Nuevos derivados de quinolina
GT200100183A (es) Derivados de quinolina y quinazolina.
UY25239A1 (es) Inhibidores de aminotiazol de quinasas dependientes de ciclinas
MX2009010790A (es) Derivados de heteroarilo biciclico fusionados.
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
BR9916566A (pt) Complexo de inibidor de ras-farnesiltransferase esulfobutiléter-7-ß-ciclodextrina ou2-hidroxipropil-ß-ciclodextrina e processo
NO324219B1 (no) Fenylpyridazin-forbindelser, medisiner og farmasoytiske preparater inneholdende disse samt anvendelse av disse for fremstilling av medikamenter for behandling av sykdom
AR090619A2 (es) Uso de un compuesto de tiazol para la produccion de un medicamento
BR9900006A (pt) Novos derivados de tiazol.
BRPI0607214B8 (pt) derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação
UY27018A1 (es) Derivados de la pirimidina
NO941135L (no) Tiazolpyrimidin derivater
ATE305926T1 (de) Pyridazin-3-on-derivate und sie enthaltende medikamente
PT1050531E (pt) Compostos piridinicos ou piperidinicos substituidos para o tratamento de doencas neurodegenerativas
NZ587591A (en) Diarylthiazole derivatives such as tetomilast as mmp-2 and/or mmp-9 inhibitors
ES2090238T3 (es) Derivados benzhidriloxietilpiperidilos de acidos alifaticos y su aplicacion en el tratamiento del asma y de sus alergias.
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
AR023058A1 (es) Derivados del tiazol, un procedimiento para su obtencion, composiciones farmaceuticas que los comprenden y el empleo de los mismos para la preparacion demedicamentos
ATE133936T1 (de) Naphthalinderivate
AR030258A1 (es) Proceso para la preparacion de derivados de tiazol y compuestos relacionados
ATE532771T1 (de) Hiv hemmende n-aminoimidazolderivate
BR9805750A (pt) Derivados de tiazol
TH64474A (th) สารสำหรับรักษาโรคปอดอุดกั้นเรื้อรัง

Legal Events

Date Code Title Description
FC Refusal